Polymorphisms in chemokine receptor 5 (CCR5) and toll-like receptor 3 (TLR3) genes were found to be a risk factors for clinical tick-borne encephalitis in the Lithuanian population [16–18]. The gene discussed is TLR3; the disease is tick-borne encephalitis.